Literature DB >> 6265358

Specificity and reversibility of chemotactic deactivation of human monocytes.

W Falk, E J Leonard.   

Abstract

The chemotactic deactivation of human monocytes was studied to provide insight into the mechanism of chemotaxis. Deactivation was dependent on the dose of chemoattractant and time of incubation. A concentration in the cell suspension of 10(-8) M N-formylmethionylleucyl phenylalanine (FMLP) for 45 min at 37 degrees C led to 60% suppression of the subsequent specific chemotactic response. Higher concentrations of FMLP led to almost 100% specific suppression. Deactivation was specific under all conditions used. The response to a nonrelated chemoattractant, human serum-derived C5a, was unaffected by incubation in FMLP. Deactivation was also transient. If cells were deactivated at 37 degrees C with FMLP, they recovered within 6 h at 37 degrees C from this deactivation. Both phenomena, deactivation and recovery from deactivation, were temperature dependent. Monocytes could not be deactivated at 0 degrees C, and they did not recover from deactivation when kept at 0 degrees C. Thus, specific deactivation appears to require cellular metabolism, involving loss of receptors or blocking of a step between receptor occupancy and response.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265358      PMCID: PMC351467          DOI: 10.1128/iai.32.2.464-468.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).

Authors:  S I Wasserman; D Whitmer; E J Geotzl; K F Austen
Journal:  Proc Soc Exp Biol Med       Date:  1975-01

2.  The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness.

Authors:  E L Becker; H J Showell; P M Henson; L S Hsu
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

Review 3.  Chemotaxis and random mobility. Clinical and biologic differentiation.

Authors:  M E Miller
Journal:  Antibiot Chemother (1971)       Date:  1974

4.  Disappearance and recovery of human monocyte IgG receptor activity after phagocytosis.

Authors:  M E Schmidt; S D Douglas
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

5.  Chemiluminescence response of phagocytizing human monocytes.

Authors:  R D Nelson; E L Mills; R L Simmons; P G Quie
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

6.  Complement-mediated granulocyte dysfunction in paroxysmal nocturnal hemoglobinuria.

Authors:  P R Craddock; J Fehr; H S Jacob
Journal:  Blood       Date:  1976-06       Impact factor: 22.113

7.  Role of a peptidase in phagocyte chemotaxis.

Authors:  S Aswanikumar; E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

8.  Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G.

Authors:  R B Johnston; J E Lehmeyer; L A Guthrie
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

9.  The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.

Authors:  P A Ward; E L Becker
Journal:  J Exp Med       Date:  1968-04-01       Impact factor: 14.307

10.  Mechanisms of the inhibition of chemotaxis by phosphonate esters.

Authors:  P A Ward; E L Becker
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

View more
  3 in total

1.  Chemotaxis of purified human monocytes in vitro: lack of accessory cell requirement.

Authors:  W Falk; E J Leonard
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

2.  Secretion of monocyte chemotactic activity by alveolar macrophages.

Authors:  E M Denholm; F M Wolber; S H Phan
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

3.  Only the chemotactic subpopulation of human blood monocytes expresses receptors for the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine.

Authors:  W Falk; L Harvath; E J Leonard
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.